Sort
35,931 grants matching “parkinsons”
A Biomedical Mass Spectrometry Resource: Ongoing Driving Biomedical Projects
$659,894Michael L Gross · Washington University · R24 · FY2022 · GM
PATHOLOG-OMICS - ESSENTIAL TREMOR IN THE BROADER CONTEXT OF NEURODEGENERATION
$659,815Elan D Louis · Yale University · R01 · FY2017 · NS
Phase I Cell Therapy for Maintaining Cholinergic Circuits in the Spectrum of Alzheimerâs Disease
$659,568Greg A. Gerhardt · University Of Kentucky · R01 · FY2024 · AG
Striatal Trans-Synaptic Signaling Mechanism in Parkinsonism
$659,307Shashank Manohar Dravid · Texas A&M University Health Science Ctr · R01 · FY2025 · NS
Dual Mechanisms of Cognitive Control
$659,197Todd Braver · Washington University · R37 · FY2017 · MH
Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands
$659,183Victoria Ahn · Confometrx, Inc. · R44 · FY2019 · MH
Personalized Functional Genomics for Mitochondrial Encephalopathy Gene Discovery
$659,162Penelope E Bonnen · Baylor College Of Medicine · R01 · FY2022 · NS
Personalized Functional Genomics for Mitochondrial Encephalopathy Gene Discovery
$659,162Penelope E Bonnen · Baylor College Of Medicine · R01 · FY2021 · NS
Personalized Functional Genomics for Mitochondrial Encephalopathy Gene Discovery
$659,162Penelope E Bonnen · Baylor College Of Medicine · R01 · FY2023 · NS
Biomarkers and Risk Factors for Prodromal Parkinson's Disease and its Progression
$659,131Alberto Ascherio · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2025 · NS
Mechanisms of gene regulation and RNA processing in synucleinopathies
$658,881Joseph R Mazzulli · Northwestern University At Chicago · R01 · FY2020 · NS
Microfabricated all-diamond microelectrode arrays for neurotransmitter sensing and extracellular recording
$658,715Wen Li · Michigan State University · R01 · FY2020 · NS
Study of protein folding and misfolding by NMR spectroscopy
$658,712Adriaan Bax · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
LRRK2 and inflammasome pathway in Parkinson's disease
$658,627Wanli W Smith · Johns Hopkins University · R01 · FY2022 · NS
Repositioning of Clinically Approved Drugs toward the Prevention and Risk Evaluation of Early Cataract Progression
$658,609Vincent M Monnier · Case Western Reserve University · R01 · FY2021 · EY
Discovering compounds with robust pro-longevity activities
$658,502Gordon J. Lithgow · Buck Institute For Research On Aging · U01 · FY2014 · AG
Thalamo-Cortical Plasticity: Sensory Denervation and Loss of Dopamine
$658,316Judith Richmon Walters · National Institute Of Neurological Disorders And Stroke · ZIA · FY2011 · NS
TWINS AND RISK OF PD: A CLINICAL AND IMAGING STUDY
$658,270Parkinson'S Institute · R01 · FY2002 · NS
Epigenetic Changes associated with Neurodegenerative Diseases
$658,267Shelley L Berger · University Of Pennsylvania · R01 · FY2012 · NS
Role of altered gut immune response in Lewy Body Disease
$658,194Kathleen Lombard Poston · Stanford University · U01 · FY2025 · DK
Closed Loop Deep Brain Stimulation for Parkinson's Disease
$658,167Philip A Starr · University Of California, San Francisco · UH3 · FY2021 · NS
Advanced MRI studies of cerebrovascular and lymphatic abnormalities in LRRK2 mouse models of Parkinson's disease
$658,091Wanli W Smith · Johns Hopkins University · R01 · FY2021 · NS
The role of brain resident T cells in Alzheimer's disease
$657,966Pamela Rosato · Dartmouth College · R01 · FY2022 · AG
ENVIRONMENTAL EPIDEMIOLOGY OF ESSENTIAL TREMOR
$657,911Columbia University Health Sciences · R01 · FY2000 · NS
Identifying Factors Predicting ACcurately End-of-Life in Dementia with Lewy Bodies and Promoting Quality End-of-Life Experiences: the PACE-DLB Study
$657,890Melissa Jo Armstrong · University Of Florida · R01 · FY2024 · AG